Novocure (NVCR) Misses Q2 EPS by 2c, Miss on Revenues

Novocure (NASDAQ: NVCR) reported Q2 EPS of ($0.24), $0.02 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $38.4 million versus the consensus estimate of $40.38 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Pembina joins proposed 1M bbl/day Alberta-to-coast pipeline plan
• Franklin Covey (FC) Misses Q3 EPS by 2c, lowers Guidance